Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
S100A11 pseudogene 5 (S100A11P5) is a noncoding genomic sequence that is homologous to the protein-coding gene S100A11, a member of the S100 family of EF-hand calcium-binding proteins. Unlike the functional S100A11 gene, which is implicated in cell proliferation, apoptosis, inflammation, and various cancers, S100A11P5 does not encode a functional protein and does not possess known biological activities. Pseudogenes such as S100A11P5 are generally not considered therapeutic targets, as they lack expression and function. Therefore, S100A11P5 is not relevant in the context of drug action, mechanisms, or biomarker development and should not be confused with the functional S100A11 gene, which has distinct and significant biological and pathological roles[1][3][5]. If the target of interest is the actual protein S100A11 (S100 calcium binding protein A11), please specify, as S100A11 is a well-studied, functional molecule with important biological roles and associations with various diseases, including cancer, inflammation, and neurological disorders[1][2][3][4][5]. However, S100A11P5 itself is a pseudogene and not a therapeutic or biological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on S100A11 pseudogene 5 (S100A11P5).